Epithelial Proliferations of Ductal Type

Seminars in Diagnostic Pathology

Volumn 21, Issue 1, 2004, Pages 10-17

  Koerner, Frederick C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atypical ductal hyperplasia; Ductal carcinoma in situ; Ductal hyperplasia

Indexed keywords

KERATIN;

BREAST CARCINOMA; BREAST DUCT; BREAST EPITHELIUM; BREAST HYPERPLASIA; CARCINOMA IN SITU; CELL HYPERPLASIA; CELL NUCLEUS; CELL POLARITY; CELL PROLIFERATION; CHROMATIN; GRANULAR CELL; IMMUNOHISTOCHEMISTRY; NUCLEOLUS; PRIORITY JOURNAL; REVIEW;

EID: 1542297692     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2003.10.010     Document Type: Article

References (17)

1. Cheatle Sir GL: Early recognition of cancer of the breast. Br Med J 1:1205-1210, 1906
2. Cheatle Sir GL: Cysts, and primary cancer in cysts, of the breast. Br J Surg 8:149-166, 1920
3. Stewart FW: Section IX - Fascicle 34. Tumors of the breast. Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington DC, 1950
4. McDivitt RW, Stewart FW, Berg JW: Tumors of the breast. Armed Forces Institute of Pathology, Washington DC, 1968
5. Azzopardi JG: Problems in breast pathology, in Bennington JL (ed), Major problems in pathology (vol 11). London, Saunders, 1979
6. Boecker W, Moll R, Dervan P, et al: Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 198:458-467, 2002
7. Raju U, Crissman JD, Zarbo RJ, et al: Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol 14:939-947, 1990
8. Page DL, Dupont WD, Rogers LW, et al: Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698-2708, 1985
9. Tavassoli FA, Norris HJ: A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518-529, 1990
10. Moinfar F, Man YG, Lininger RA, et al: Use of keratin 34E12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type - Benign and malignant intraductal proliferations. Am J Surg Pathol 23:1048-1057, 1999
11. Böcker W, Bier B, Freytag G, et al: An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Virchows Archiv A Pathol Anat 421:323-330, 1992
12. Boecker W, Buerger H, Schmitz K, et al: Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-miolecular-weight cytokeratin expression patterns. J Pathol 195:415-421, 2001
13. Otterbach F, Bankfalvi A, Bergner S, et al: Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37:232-240, 2000
14. Lacroix-Triki M, Mery E, Voigt J-J, et al: Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34βE12 antibody. Virchows Archiv 442:548-554, 2003
15. McDivitt RW, Holleb AI, Foote FW: Prior breast disease in patients treated for papillary carcinoma. Arch Pathol 85:117-124, 1968
16. Azzopardi JG: Benign and malignant proliferative epithelial lesions of the breast; a review. Eur J Cancer Clin Oncol 19:1717-1720, 1985
17. Walker R: Are all ductal proliferations of the breast premalignant? J Pathol 195:401-403, 2001